Cytochrome P450 (CYP450) gene testing is currently not recommended to guide treatment with selective serotonin reuptake inhibitor (SSRI) drugs for patients with depression, concludes an expert panel report in the December issue of Genetics in Medicine, published by the American College of Medical Genetics (ACMG) and by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health. [click link for full article]
Popularity: unranked [?]
Related posts:
- Evidence Doesn’t Support CYP450 Gene Testing Before Antidepressant Treatment
- Electroconvulsive Therapy Is Effective But Underused For Severe Depression
- Gene Variations In Diverse Patient Populations Determine Who Responds Best To An Antidepressant
- New Pacemaker-Like Device Offers Hope To Those Living With Treatment-Resistant Depression
- New Pacemaker-Like Device Offers Hope To Those Living With Treatment-Resistant Depression
Comments
No Responses to “Evidence Doesn’t Support CYP450 Gene Testing Before Antidepressant Treatment”